Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SinEcch is a commercially available homeopathic product developed by Alpine Pharmaceuticals, specifically designed to reduce postoperative bruising (ecchymosis), swelling (edema), and pain. The product consists of a programmed dosage regimen of *Arnica montana* in two different homeopathic potencies: three capsules of 1M (high potency) and nine capsules of 12C (low potency), for a total of 12 capsules taken over a four-day period starting on the day of surgery. As a homeopathic preparation, its mechanism of action is based on the principles of homeopathy rather than conventional pharmacological target binding. It has been evaluated in various clinical settings, including a randomized, double-blind, placebo-controlled trial at Tufts University School of Dental Medicine for patients undergoing third molar (wisdom tooth) extractions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on SinEcch.